Synthesis and Properties of 2′-Deoxyadenosine Mimics Bearing a Thieno[3,2-d]pyrimidine Ring

Yasufumi Fuchi; Miho Kawaguchi; Yuta Ito; Yoshiyuki Hari

doi:10.1055/s-0042-1751508

Synlett, Table of Contents

Synlett 2024; 35(06): 716-720
DOI: 10.1055/s-0042-1751508

cluster

Special Issue to Celebrate the Centenary Year of Prof. Har Gobind Khorana

Synthesis and Properties of 2′-Deoxyadenosine Mimics Bearing a Thieno[3,2-d]pyrimidine Ring

Yasufumi Fuchi

,

Miho Kawaguchi

,

Yuta Ito

,

Yoshiyuki Hari ∗

Abstract

All articles of this category

Abstract

A C-nucleoside with a stable C–C glycosidic bond can be used as a building block for chemically modified oligonucleotides (ONs). In this study, two adenosine-like C-nucleosides (d^SA and d^SO2A) bearing thieno[3,2-d]pyrimidine rings were designed and synthesized. These analogues were synthesized via the Heck reaction, and their properties as monomer nucleosides were investigated. Both the d^SA and d^SO2A monomers were not recognized by adenosine deaminase (ADA). In addition, they exhibited fluorescence emissions in the UV and visible regions of d^SA and d^SO2A, respectively. Subsequently, d^SA was converted into a phosphoramidite compound and incorporated into the ONs. The synthesized d^SA-modified ONs formed a stable duplex with DNA and RNA complements comparable to natural adenosine. Furthermore, the modified ONs exhibited fluorescence emission derived from d^SA.

Key words

C-nucleoside - adenosine mimic - thienopyrimidine - oligonucleotide - fluorescence

Full Text

References

References and Notes
1 Zhang M, Kong L, Gong R, Iorio M, Donadio S, Deng Z, Sosio M, Chen W. Microb. Cell Fact. 2022; 21: 1

2a Cohn WE. J. Biol. Chem. 1960; 235: 1488
2b Cohn WE. Biochim. Biophys. Acta 1959; 32: 569

3a Nishimura H, Mayama M, Komatsu Y, Kato H, Shimaoka N, Tanaka Y. J Antibiot. 1964; 17: 148
3b Nakagawa Y, Kano H, Tsukuda Y, Koyama H. Tetrahedron Lett. 1967; 8: 4105

4a Koyama G, Maeda K, Umezawa H, Iitaka Y. Tetrahedron Lett. 1966; 7: 597
4b Robins RK, Townsend LB, Cassidy F, Gerster JF, Lewis AF, Miller RL. J. Heterocycl. Chem. 1966; 3: 110
4c Wang SA, Ko Y, Zeng J, Geng Y, Ren D, Ogasawara Y, Irani S, Zhang Y, Liu HW. J. Am. Chem. Soc. 2019; 141: 6127

5a Morais P, Adachi H, Yu YT. Front. Cell Dev. Biol. 2021; 9: 1
5b Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D. Mol. Ther. 2008; 16: 1833

6a Bzowska A, Kulikowska E, Shugar D. Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 1992; 1120: 239
6b Long MC, Parker WB. Biochem. Pharmacol. 2006; 71: 1671
6c Wierzchowski J, Antosiewicz JM, Shugar D. Mol. Biosyst. 2014; 10: 2756

7a Ward DC, Reich E. Proc. Natl. Acad. Sci. U.S.A. 1968; 61: 1494
7b Ward DC, Cerami A, Reich E, Acs G, Altwerger L. J. Biol. Chem. 1969; 244: 3243

8a De Clercq E. J. Med. Chem. 2016; 59: 2301
8b Eastman RT, Roth JS, Brimacombe KR, Simeonov A, Shen M, Patnaik S, Hall MD. ACS Cent. Sci. 2020; 6: 672
8c Cho A, Zhang L, Xu J, Babusis D, Butler T, Lee R, Saunders OL, Wang T, Parrish J, Perry J, Feng JY, Ray AS, Kim CU. Bioorg. Med. Chem. Lett. 2012; 22: 4127

9a Shin D, Sinkeldam RW, Tor Y. J. Am. Chem. Soc. 2011; 133: 14912
9b Rovira AR, Fin A, Tor Y. J. Am. Chem. Soc. 2015; 137: 14602
9c Rovira AR, Fin A, Tor Y. Chem. Sci. 2017; 8: 2983

10a Park S, Otomo H, Zheng L, Sugiyama H. Chem. Commun. 2014; 50: 1573
10b Lefoix M, Mathis G, Kleinmann T, Truffert J.-C, Asseline U. J. Org. Chem. 2014; 79: 3221

11 Shao X, Abdelkhalek A, Abutaleb NS, Velagapudi UK, Yoganathan S, Seleem MN, Talele TT. J. Med. Chem. 2019; 62: 9772
12 Temburnikar KW, Zimmermann SC, Kim NT, Ross CR, Gelbmann C, Salomon CE, Wilson GM, Balzarini J, Seley-Radtke KL. Bioorg. Med. Chem. 2014; 22: 2113
13 Kemnitzer W, Sirisoma N, May C, Tseng B, Drewe J, Cai SX. Bioorg. Med. Chem. Lett. 2009; 19: 3536
14 Tor Y, Del Valle S, Jaramillo D, Srivatsan SG, Rios A, Weizman H. Tetrahedron 2007; 63: 3608

15a Wellington KW, Benner SA. Nucleosides, Nucleotides Nucleic Acids 2006; 25: 1309
15b Stambaský J, Hocek M, Kočovský P. Chem. Rev. 2009; 109: 6729

16 Hegelein A, Müller D, Größl S, Göbel M, Hengesbach M, Schwalbe H. Chem. Eur. J. 2020; 26: 1800
17 Synthesis of d^SA To a solution of compound 5 (38 mg, 70 μmol) in CH₂Cl₂ (1 mL), TFA (0.2 mL) was added at room temperature under an argon atmosphere. The reaction mixture was stirred for 17 h followed by addition of MeOH. The resulting mixture was concentrated in vacuo. Subsequently, CHCl₃ was added to the residue, and the resulting precipitate was collected by filtration. The collected solid was dried in vacuo to obtain compound d^SA (15 mg, 81%) as a white solid. IR (ATR): 3329, 3200, 2924, 1643, 1579, 1513 cm^–1. ¹H NMR (500 MHz, CD₃OD): δ = 8.33 (1 H, s), 7.98 (1 H, s), 5.49 (1 H, dd, J = 11.0, 5.5 Hz), 4.46 (1 H, d, J = 5.5 Hz), 4.06–4.05 (1 H, m), 3.81 (1 H, dd, J = 12.0, 3.0 Hz), 3.71 (1 H, dd, J = 12.0, 3.0 Hz), 2.42 (1 H, ddd, J = 13.0, 11.0, 5.5 Hz), 2.22 (1 H, dd, J = 13.0, 5.5 Hz). ¹³C NMR (125 MHz, CD₃OD): δ = 160.4, 157.7, 154.8, 138.1, 131.4, 117.4, 89.7, 77.9, 75.2, 64.5, 58.3, 49.8, 43.0, 18.4. HRMS (ESI-TOF): m/z [M – H]^– calcd for C₁₁H₁₂N₃O₃S: 266.0599; found: 266.0599.
18 Synthesis of d^SO2A To a solution of compound 9 (289 mg, 0.5 mmol) in CH₂Cl₂ (5 mL), TFA (0.25 mL) was added at room temperature under an argon atmosphere. The reaction mixture was stirred for 2 days and then quenched with NaHCO₃ and MeOH. The resulting mixture was filtered, and then the filtrate was concentrated in vacuo. Subsequently, a solution of CHCl₃/MeOH (1:1) was added to the residue, and the resulting precipitate was collected by filtration. The collected solid was dried in vacuo to obtain compound d^SO2A (92 mg, 62%) as a gray solid. IR (ATR): 3508, 3376, 3331, 3135, 3084, 1670, 1591, 1537, 1499 cm^–1. ¹H NMR (500 MHz, DMSO-d ₆): δ = 8.58 (1 H, s), 7.95 (2 H, br s), 7.46 (1 H, d, J = 2.0 Hz), 5.15 (1 H, d, J = 5.0 Hz), 5.12 (1 H, ddd, J = 10.0, 6.0, 2.0, Hz), 4.77 (1 H, t, J = 6.0 Hz), 4.19–4.18 (1 H, m), 3.80 (1 H, dt, J = 5.0, 2.0 Hz), 3.45–3.36 (2 H, m), 2.31 (1 H, ddd, J = 13.0, 6.0, 2.0 Hz), 1.79 (1 H, ddd, J = 13.0, 10.0, 5.0 Hz). ¹³C NMR (125 MHz, DMSO-d ₆): δ = 162.2, 158.1, 154.4, 148.1, 129.2, 109.0, 87.6, 72.9, 71.8, 62.0, 40.5. HRMS (ESI-TOF): m/z [M + Na]⁺ calcd for C₁₁H₁₃N₃O₅NaS: 322.0468; found: 322.0474.
19 Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. Med. Res. Rev. 2001; 21: 105
20 An authentic sample of d^SI was successfully obtained in 78% yield by the chemical conversion of d^SA (see the Supporting Information). In contrast, for the preparation of an authentic sample of d^SO2I, the chemical conversion of d^SO2A into the corresponding d^SO2I could not be achieved because of the low reactivity of the 4-amino group of d^SO2A.
21 Sinkeldam RW, McCoy LS, Shin D, Tor Y. Angew. Chem. Int. Ed. 2013; 52: 14026
22 Ludford PT, Yang S, Bucardo MS, Tor Y. Chem. Eur. J. 2022; 28: e202104472
23 Chen RF. Anal. Lett. 1967; 1: 35
24 Heinlein T, Knemeyer JP, Piestert O, Sauer M. J. Phys. Chem. B 2003; 107: 7957

Supplementary Material

Supporting Information